Non-Hodgkin Lymphoma
Filter Results
Nomograms for predicting overall survival and cancer-specific survival in patients with head and neck non-Hodgkin lymphoma: A population-based study
This study aimed to develop comprehensive nomograms for patients with head and neck non-Hodgkin lymphoma (H&NNHL) to determine their overall survival (OS) and cancer-specific survival (CSS). In this study, 602 H&NNHL patients were analyzed from the Surveillance, Epidemiology, and End Results database.
Non-Hodgkin lymphoma of a palate A case report of a highly destructive lesion
Non-Hodgkin lymphoma (NHL) is a haematolymphoid neoplasm that can affect nodal and extra-nodal sites. It is a rare disease in the oral cavity, accounting for only 2% of all extra-nodal lymphomas. Its aetiology is multi-factorial, being strongly associated with viral infections.
An Unusual Case of High-Grade Non-Hodgkin Lymphoma Masquerading as Acute Pyelonephritis with Acute Kidney Injury
Renal involvement in non-Hodgkin lymphoma (NHL) has been reported to present with glomerulonephritis, acute kidney injury (AKI), and lymphoma infiltrating the kidney parenchyma
A rare localization of a common disease Primary uterine Non-Hodgkin lymphoma mimicking leiomyosarcoma
Genitourinary system lymphomas comprise a small part of extra-nodal lymphomas (ENLs). ENLs of uterine origin are extremely rare and are often confused with gynecological malignancies. We present an 80-year-old female patient diagnosed with diffuse large B-cell lymphoma (DLBCL) with a single focus of the uterus.
Fatal outcome of non-Hodgkin B cell lymphoblastic lymphoma: A case report
B-lymphoblastic lymphoma is more slow-growing than T-LL and can be found in the skin, bone, or lymph nodes. Lymphoblastic lymphoma can be spread all over the body parts, including the brain and spinal cord (cerebrospinal fluid), in a male to the testes.
Immune targeted therapy for diffuse large B cell lymphoma
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma, is highly heterogeneous and invasive.
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study
Real-world evidence on non-Hodgkin lymphoma (NHL) management in Latin America is currently lacking. The objective of this study was to describe treatment characteristics and outcomes of NHL in Latin America.
Primary biliary non-Hodgkin's lymphoma. A case report
Primary biliary non-Hodgkin's lymphoma (PBNHL) is a rare disease with only 41 cases reported since 1982. The incidence of PBNHL in patients with malignant cholangiocarcinoma was 0.6%, and PBNHL accounted for 0.4% of extranodal non-Hodgkin's lymphoma, and only 0.016% of all non-Hodgkin's lymphoma cases.
Clinical Trials of Interest
At MD Anderson, the intent is ‘to have a clinical trial available for everybody who comes through the door,’ says its section chief, Chronic Lymphocytic Leukemia, Department of Leukemia, Division of Cancer Medicine, William G. Wierda, MD, PhD.